Testosterone therapy in men with Klinefelter syndrome has been found to improve quality of life and nearly halve mortality rates.

Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.

Demand for the hormone is surging, and not just to treat libido. Here’s what we know about its benefits, and potential risks.

Testosterone treatment significantly reduces mortality among men with Klinefelter syndrome. Researcher calls for changes in ...

Testosterone recovery was associated with improved OS in patients with high-risk prostate cancer treated with ADT and radiotherapy.

Marius Pharmaceuticals is pleased to announce that Thrive, a leading provider of personalized healthcare solutions and a trusted partner of O2 Fitness, now offers KYZATREX® (testosterone undecanoate) ...

Testosterone treatment significantly reduces mortality among men with Klinefelter syndrome. Researcher calls for changes in guidelines to ensure more patients receive the necessary treatment.

Prostate-specific antigen responses were similar between transdermal estradiol and hormone therapy combined with androgen receptor inhibitors in prostate cancer.

Responses were similar among patients with estrogen patches and ARPIs compared to luteinizing hormone releasing hormone ...

A mid-stage study reveals that transdermal estradiol patches may match traditional androgen deprivation therapy in treating prostate cancer with fewer side effects. This approach boosts bone density ...

Summary: Limitless TRT & Aesthetics has opened a new location in Chandler, Arizona, as part of its strategic expansion, increasing access to ...